Tryptophan hydroxylase, the initial and rate-limiting enzyme in serotonin biosynthesis, is inactivated by peroxynitrite in a concentration-dependent manner. This effect is prevented by molecules that react directly with peroxynitrite such as dithiothreitol, cysteine, glutathione, methionine, tryptophan, and uric acid but not by scavengers of superoxide (superoxide dismutase), hydroxyl radical (Me 2 SO, mannitol), and hydrogen peroxide (catalase). Assuming simple competition kinetics between peroxynitrite scavengers and the enzyme, a second-order rate constant of 3.4 ؋ 10 4 M ؊1 s ؊1 at 25°C and pH 7.4 was estimated. The peroxynitrite-induced loss of enzyme activity was accompanied by a concentration-dependent oxidation of protein sulfhydryl groups. Peroxynitrite-modified tryptophan hydroxylase was resistant to reduction by arsenite, borohydride, and dithiothreitol, suggesting that sulfhydryls were oxidized beyond sulfenic acid. Peroxynitrite also caused the nitration of tyrosyl residues in tryptophan hydroxylase, with a maximal modification of 3.8 tyrosines/monomer. Sodium bicarbonate protected tryptophan hydroxylase from peroxynitrite-induced inactivation and lessened the extent of sulfhydryl oxidation while causing a 2-fold increase in tyrosine nitration. Tetranitromethane, which oxidizes sulfhydryls at pH 6 or 8, but which nitrates tyrosyl residues at pH 8 only, inhibited tryptophan hydroxylase equally at either pH. Acetylation of tyrosyl residues with N-acetylimidazole did not alter tryptophan hydroxylase activity. These data suggest that peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Modification of tyrosyl residues by peroxynitrite plays a relatively minor role in the inhibition of tryptophan hydroxylase catalytic activity.Tryptophan hydroxylase (TPH, 1 EC 1.14.16.4; L-tryptophan,tetrahydrobiopterin:oxygen oxidoreductase (5-hydroxylating)) is the initial and rate-limiting enzyme in the biosynthesis of the neurotransmitter serotonin. The physiological roles for serotonin are diverse and include modulation of sleep, thermoregulation, and food intake (1). From a clinical perspective, alterations in serotonin function have been implicated in several neuropsychiatric disorders such as depression, obsessive-compulsive disorder, and suicide (2). Alterations in TPH activity produce corresponding changes in the synaptic levels of serotonin (3), suggesting that TPH can have influences on serotonin neurochemical function that extend well beyond its role in fulfilling the first step in serotonin synthesis from tryptophan. Drugs that cause long term changes in TPH activity could well change serotonin synaptic function to the detriment of normal physiological and behavioral function. For example, the neurotoxic amphetamines methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") significantly reduce TPH activity and serotonin levels (4). Long term abuse of these drugs produces behavioral and psychiatric conditions indicative of diminished serotonin function (5, 6). Because the...